The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter, randomized phase II study of epcoritamab for patients with large B-cell lymphomas achieving a partial response after CD19-directed CAR T-cell therapy (CAR-T).
 
Allison Marie Bock
Honoraria - Primum
Consulting or Advisory Role - Abbvie/Pharmacyclics
Research Funding - Abbvie/Pharmacyclics (Inst); Genmab (Inst)
 
Sandeep Raj
Research Funding - Abbvie/Pharmacyclics (Inst); Genmab (Inst)
 
Sharmila Giri
No Relationships to Disclose
 
Lori Ann Leslie
Consulting or Advisory Role - Abbvie; AstraZeneca/Merck; BeiGene; Celgene/Bristol-Myers Squibb; Epizyme; Janssen/Pharmacyclics; Kite/Gilead; Lilly; Merck; Seagen; TG Therapeutics
Speakers' Bureau - Abbvie; AstraZeneca; BeiGene; Celgene; Epizyme; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Lilly; Pharmacyclics; Seagen; TG Therapeutics
 
Dilan Anil Patel
No Relationships to Disclose
 
Madiha Iqbal
No Relationships to Disclose
 
Natalie Sophia Grover
Stock and Other Ownership Interests - Sangamo Therapeutics
Honoraria - ADC Therapeutics; Bristol Myers Squibb Foundation; Caribou Biosciences; Genentech; Kite, a Gilead company; Novartis; Ono Pharmaceutical; Seagen
Consulting or Advisory Role - Regeneron
Research Funding - Tessa Therapeutics
 
Boyu Hu
Honoraria - Guidepoint Inc
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb/Celgene; Caribou Biosciences; Genmab; ImmPACT Bio; Lilly; Novartis; Regeneron; Seagen
Speakers' Bureau - Binacea; Curio Science; OncLive/MJH Life Sciences; Patient Power; Total Health Conferencing
Research Funding - Artiva (Inst); AstraZeneca (Inst); Caribou Biosciences (Inst); Celgene (Inst); crispr therapeutics (Inst); ImmPACT Bio (Inst); MorphoSys/Incyte (Inst); Newave Pharmaceutical (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - DAVA Oncology
 
Miguel-Angel Perales
No Relationships to Disclose
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Bantam Pharmaceutical; Celgene (Inst); Debiopharm Group; Genentech (Inst); Karyopharm Therapeutics; Kite/Gilead; kymera; MorphoSys (Inst); Ryvu Therapeutics; Selvita; TG Therapeutics
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)